Evandro Chagas National Institute of Infectious Disease: Clinical Trials

8 trials sponsored by Evandro Chagas National Institute of Infectious Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 recruiting. 4 Not applicable, 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Unknown 1
Phase 33Completed 2, Recruiting 1
Phase 21Completed 1

Follow Evandro Chagas National Institute of Infectious Disease: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
Cabotegravir Injection - HIV Infections
Phase 3RecruitingEvandro Chagas National Institute of Infectious Disease12002022-09-202024-10-08
Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL
Data collection - Covid19, Hospitalization
UnknownEvandro Chagas National Institute of Infectious Disease35002020-07-252021-03-19
Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study
HIV testing - HIV Infections, Risk Reduction
Not applicableCompletedEvandro Chagas National Institute of Infectious Disease40002019-10-012023-01-06
The BeT Study Intervention to Reduce Disparities in HIV Prevention and Care
Interview - AIDS and Infections, HIV Prevention
Not applicableUnknownEvandro Chagas National Institute of Infectious Disease1502019-02-012022-03-29
Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil
Primaquine - P Vivax, Malaria, Vivax
Not applicableCompletedCenters for Disease Control and Prevention2572018-04-092021-08-09
Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil
Artemether-lumefantrine combination - Malaria
Not applicableCompletedCenters for Disease Control and Prevention792015-12-012017-10-09
Physical Exercise Program in Chronic Chagas Heart Disease
Exercise, nutritional and pharmaceutical counceling, Nutritional and pharmaceutical counceling - Chagas Disease, Chagas Cardiomyopathy
Phase 3CompletedEvandro Chagas National Institute of Infectious Disease302015-03-012017-07-27
Cardiac Rehabilitation in Chagas Heart Failure
Exercise, nutritional and pharmaceutical counseling - Chagas Disease, Chagas Cardiomyopathy
Phase 2 / Phase 3CompletedEvandro Chagas National Institute of Infectious Disease122013-05-012015-08-05

Conditions studied

Chagas Cardiomyopathy (2)  ·  Chagas Disease (2)  ·  HIV Infections (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  COVID-19 (1)  ·  HIV Seropositivity (1)  ·  Health Risk Behaviors (1)  ·  Helping Behavior (1)  ·  Infections (1)  ·  Malaria (1)  ·  Malaria, Vivax (1)  ·  Motor Activity (1)  ·  Risk Reduction Behavior (1)  ·  Risk-Taking (1)  ·  Social Stigma (1)

Interventions

Exercise (2)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  Data Collection (1)  ·  HIV Testing (1)  ·  Interviews as Topic (1)  ·  Primaquine (1)  ·  cabotegravir (1)

Countries

Brazil (8)

Top investigators

Alexandre Macedo de Oliveira, MD (2)  ·  Andrea S Sousa, PhD (1)  ·  Beatriz Grinsztejn, MD, PhD (1)  ·  Fernanda Mendes, M.D. (1)  ·  Valdilea Veloso, MD, PhD (1)

Results publications

PMID 27590681, PMID 35353962, PMID 36735296, PMID 37074775, PMID 38076411, PMID 38589582, PMID 39446416, PMID 40600468, PMID 42325473, PMID 42785335

NIH funding

5UG3HD096914 (1)